Fund Holdings — Caligan Partners LP

Total Portfolio Value:
$720.67M
Total Bought:
$206.38M
Total Sold:
$288.56M
Net Transaction:
-$82.18M
Notable People:
Caligan Partners Gp Llc
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Liquidia Corporation(LQDA)8,118,8928,118,8920$101.16M$184.62M25.62%+$83.46M
ABIVAX Société AnonymeADS(ABVX)1,674,4001,451,924-222,476$12.81M$123.27M17.10%+$110.46M
Mineralys Therapeutics, Inc.(MLYS)2,017,3522,772,654+755,302$27.29M$105.14M14.59%+$77.84M
Exelixis, Inc.(EXEL)1,525,7301,525,7300$67.25M$63.01M8.74%-$4.23M
Revolution Medicines, Inc.(RVMD)636,8351,064,249+427,414$23.43M$49.70M6.90%+$26.27M
Agios Pharmaceuticals, Inc.(AGIO)1,071,2581,131,205+59,947$35.63M$45.41M6.30%+$9.78M
Adma Biologics Inc02,636,609+2,636,609$0$38.65M5.36%+$38.65M
Evolus, Inc.(EOLS)3,341,9704,138,943+796,973$30.78M$25.41M3.53%-$5.37M
Merus N V656,999216,954-440,045$34.56M$20.43M2.83%-$14.13M
Xenon Pharmaceuticals Inc.(XENE)0444,565+444,565$0$17.85M2.48%+$17.85M
Anika Therapeutics Inc1,435,1301,435,1300$15.18M$13.49M1.87%-$1.69M
Avalo Therapeutics, Inc.(AVTX)0833,333+833,333$0$10.59M1.47%+$10.59M
Tyra Biosciences, Inc.(TYRA)189,950696,825+506,875$1.82M$9.75M1.35%+$7.93M
Inhibrx Biosciences, Inc.(INBX)0236,383+236,383$0$7.96M1.10%+$7.96M
Verrica Pharmaceuticals Inc.(VRCA)0923,910+923,910$0$3.98M0.55%+$3.98M
Aura Biosciences, Inc.(AURA)200,000227,174+27,174$1.25M$1.40M0.19%+$151.9K
BioCryst Pharmaceuticals, Inc.(BCRX)638,9080-638,908$5.72M$0—-$5.72M
Rezolute, Inc.(RZLT)1,543,0140-1,543,014$6.88M$0—-$6.88M
Verona Pharma PlcADS1,436,8780-1,436,878$135.90M$0—-$135.90M
Verrica Pharmaceuticals Inc.(VRCA)9,239,1190-9,239,119$4.90M$0—-$4.90M
Y-Mabs Therapeutics Inc2,342,6090-2,342,609$10.57M$0—-$10.57M
Page 1 of 1
Caligan Partners LP — 13F Holdings — Q3 2025 | TickerTrail